BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29476293)

  • 1. Whole-exome sequencing of a meningeal melanocytic tumour reveals activating CYSLTR2 and EIF1AX hotspot mutations and similarities to uveal melanoma.
    Küsters-Vandevelde HVN; Germans MR; Rabbie R; Rashid M; Ten Broek R; Blokx WAM; Prinsen CFM; Adams DJ; Ter Laan M
    Brain Tumor Pathol; 2018 Apr; 35(2):127-130. PubMed ID: 29476293
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients.
    Hou C; Xiao L; Ren X; Tang F; Guo B; Zeng W; Liang C; Yan N
    Ophthalmic Res; 2020; 63(3):358-368. PubMed ID: 31614358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular melanocytoma diagnosis confirmed by gene mutation profile.
    Knappe UJ; Tischoff I; Tannapfel A; Reinbold WD; Möller I; Sucker A; Schadendorf D; Griewank KG; van de Nes JAP
    Neuropathology; 2018 Jun; 38(3):288-292. PubMed ID: 29226425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.
    Küsters-Vandevelde HV; Creytens D; van Engen-van Grunsven AC; Jeunink M; Winnepenninckx V; Groenen PJ; Küsters B; Wesseling P; Blokx WA; Prinsen CF
    Acta Neuropathol Commun; 2016 Jan; 4():5. PubMed ID: 26769193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors.
    van de Nes JAP; Koelsche C; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Pietsch T; Murali R; Schadendorf D; Griewank KG
    J Invest Dermatol; 2017 Sep; 137(9):2033-2035. PubMed ID: 28499758
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma.
    Nell RJ; Menger NV; Versluis M; Luyten GPM; Verdijk RM; Madigan MC; Jager MJ; van der Velden PA
    BMC Cancer; 2021 Feb; 21(1):164. PubMed ID: 33588787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.
    Martin M; Maßhöfer L; Temming P; Rahmann S; Metz C; Bornfeld N; van de Nes J; Klein-Hitpass L; Hinnebusch AG; Horsthemke B; Lohmann DR; Zeschnigk M
    Nat Genet; 2013 Aug; 45(8):933-6. PubMed ID: 23793026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
    Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic genomic and translational efficiency studies of uveal melanoma.
    Johnson CP; Kim IK; Esmaeli B; Amin-Mansour A; Treacy DJ; Carter SL; Hodis E; Wagle N; Seepo S; Yu X; Lane AM; Gragoudas ES; Vazquez F; Nickerson E; Cibulskis K; McKenna A; Gabriel SB; Getz G; Van Allen EM; 't Hoen PAC; Garraway LA; Woodman SE
    PLoS One; 2017; 12(6):e0178189. PubMed ID: 28594900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal Melanomas Harbor Recurrent Activating Mutations in CYSLTR2.
    Cancer Discov; 2016 Jun; 6(6):573. PubMed ID: 27150534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
    Yavuzyigitoglu S; Koopmans AE; Verdijk RM; Vaarwater J; Eussen B; van Bodegom A; Paridaens D; Kiliç E; de Klein A;
    Ophthalmology; 2016 May; 123(5):1118-28. PubMed ID: 26923342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma.
    Moore AR; Ceraudo E; Sher JJ; Guan Y; Shoushtari AN; Chang MT; Zhang JQ; Walczak EG; Kazmi MA; Taylor BS; Huber T; Chi P; Sakmar TP; Chen Y
    Nat Genet; 2016 Jun; 48(6):675-80. PubMed ID: 27089179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.
    Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE
    JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis.
    Küsters-Vandevelde HV; Kruse V; Van Maerken T; Boterberg T; Pfundt R; Creytens D; Van den Broecke C; Machielsen TC; Koelsche C; von Deimling A; Küsters B; Groenen PJ; Wesseling P; Blokx WA
    Exp Mol Pathol; 2017 Feb; 102(1):25-31. PubMed ID: 27974237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.
    Dono M; Angelini G; Cecconi M; Amaro A; Esposito AI; Mirisola V; Maric I; Lanza F; Nasciuti F; Viaggi S; Gualco M; Bandelloni R; Truini M; Coviello DA; Zupo S; Mosci C; Pfeffer U
    Br J Cancer; 2014 Feb; 110(4):1058-65. PubMed ID: 24423917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
    Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
    JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling.
    Ceraudo E; Horioka M; Mattheisen JM; Hitchman TD; Moore AR; Kazmi MA; Chi P; Chen Y; Sakmar TP; Huber T
    J Biol Chem; 2021; 296():100163. PubMed ID: 33288675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal rearrangements in uveal melanoma: Chromothripsis.
    van Poppelen NM; Yavuzyigitoglu S; Smit KN; Vaarwater J; Eussen B; Brands T; Paridaens D; Kiliç E; de Klein A
    Genes Chromosomes Cancer; 2018 Sep; 57(9):452-458. PubMed ID: 29726589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.